Literature DB >> 7721825

Identification of the major tyrosine kinase substrate in signaling complexes formed after engagement of Fc gamma receptors.

A Marcilla1, O M Rivero-Lezcano, A Agarwal, K C Robbins.   

Abstract

We have recently identified the protein product of the c-cbl proto-oncogene as an SH3 binding protein expressed in macrophages. To investigate the possibility that p120c-cbl is involved in signaling pathways initiated by cell surface receptors for IgG (Fc gamma R), lysates of HL60 cells were examined for tyrosine phosphorylation of p120c-cbl upon Fc gamma R engagement. Our findings demonstrate that p120c-cbl is tyrosine-phosphorylated upon Fc gamma R engagement and that this molecule represents the major tyrosine kinase substrate in this signaling pathway. Protein complexes containing p120c-cbl, p72syk, and p56lyn were observed either in resting or activated cells. In vitro studies showed that the direct association between p120c-cbl and p56lyn was mediated by the SH3 domain of p56lyn.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7721825     DOI: 10.1074/jbc.270.16.9115

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  14 in total

1.  Transmodulation of BCR signaling by transduction-incompetent antigen receptors: implications for impaired signaling in anergic B cells.

Authors:  Barbara J Vilen; Kathy M Burke; Michelle Sleater; John C Cambier
Journal:  J Immunol       Date:  2002-05-01       Impact factor: 5.422

2.  Identification of microglial signal transduction pathways mediating a neurotoxic response to amyloidogenic fragments of beta-amyloid and prion proteins.

Authors:  C K Combs; D E Johnson; S B Cannady; T M Lehman; G E Landreth
Journal:  J Neurosci       Date:  1999-02-01       Impact factor: 6.167

3.  FcgammaRIII engagement provides activating signals to NKT cells in antibody-induced joint inflammation.

Authors:  Hye Young Kim; Sanghee Kim; Doo Hyun Chung
Journal:  J Clin Invest       Date:  2006-08-17       Impact factor: 14.808

4.  The effect of insulin and exercise on c-Cbl protein abundance and phosphorylation in insulin-resistant skeletal muscle in lean and obese Zucker rats.

Authors:  G D Wadley; C R Bruce; N Konstantopoulos; S L Macaulay; K F Howlett; J A Hawley; D Cameron-Smith
Journal:  Diabetologia       Date:  2004-01-17       Impact factor: 10.122

5.  A beta 1 integrin signaling pathway involving Src-family kinases, Cbl and PI-3 kinase is required for macrophage spreading and migration.

Authors:  F Meng; C A Lowell
Journal:  EMBO J       Date:  1998-08-03       Impact factor: 11.598

6.  Tissue hyperplasia and enhanced T-cell signalling via ZAP-70 in c-Cbl-deficient mice.

Authors:  M A Murphy; R G Schnall; D J Venter; L Barnett; I Bertoncello; C B Thien; W Y Langdon; D D Bowtell
Journal:  Mol Cell Biol       Date:  1998-08       Impact factor: 4.272

7.  Wiskott-Aldrich syndrome protein physically associates with Nck through Src homology 3 domains.

Authors:  O M Rivero-Lezcano; A Marcilla; J H Sameshima; K C Robbins
Journal:  Mol Cell Biol       Date:  1995-10       Impact factor: 4.272

8.  Activation of phosphatidylinositol 3-kinase by concanavalin A through dual signaling pathways, G-protein-coupled and phosphotyrosine-related, and an essential role of the G-protein-coupled signals for the lectin-induced respiratory burst in human monocytic THP-1 cells.

Authors:  T Matsuo; K Hazeki; O Hazeki; T Katada; M Ui
Journal:  Biochem J       Date:  1996-04-15       Impact factor: 3.857

9.  Cbl suppresses B cell receptor-mediated phospholipase C (PLC)-gamma2 activation by regulating B cell linker protein-PLC-gamma2 binding.

Authors:  T Yasuda; A Maeda; M Kurosaki; T Tezuka; K Hironaka; T Yamamoto; T Kurosaki
Journal:  J Exp Med       Date:  2000-02-21       Impact factor: 14.307

10.  Characterization of Cbl tyrosine phosphorylation and a Cbl-Syk complex in RBL-2H3 cells.

Authors:  Y Ota; L O Beitz; A M Scharenberg; J A Donovan; J P Kinet; L E Samelson
Journal:  J Exp Med       Date:  1996-11-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.